Demodex Blepharitis
Definition
Blepharitis caused by infestation of the eyelid follicles and meibomian glands by Demodex mites (primarily D. folliculorum and D. brevis), characterized by cylindrical dandruff at the lash base, lid margin inflammation, and associated ocular surface disease.
Clinical Snapshot
Demodex blepharitis is caused by infestation of the eyelid follicles (D. folliculorum) and meibomian glands (D. brevis) by Demodex mites — the most common ectoparasite in humans. Cylindrical dandruff (CD) at the lash base is the pathognomonic sign. Demodex infestation is extraordinarily prevalent, increasing with age, and is a significant and underdiagnosed contributor to chronic blepharitis, MGD, and ocular surface disease. Xdemvy® (iotilaner 0.5%) is the first FDA-approved targeted treatment.
Epidemiology
Demodex infestation is nearly universal in adults over 60, with prevalence increasing from approximately 20% in the third decade to over 95% in adults over 70. Clinically significant Demodex blepharitis — with symptoms and signs attributable to infestation — is estimated to affect 25 million Americans.
Pathophysiology
D. folliculorum inhabits the lash follicles and feeds on epithelial cells; D. brevis inhabits the meibomian glands and sebaceous glands. Mites mechanically obstruct follicles and gland orifices, carry bacteria (particularly Bacillus oleronius) that trigger inflammatory responses, and deposit waste products that stimulate lid margin inflammation. The resulting inflammation contributes to MGD, tear film instability, and ocular surface disease. Mite populations are regulated by the immune system — immunocompromised patients and those with rosacea are at higher risk of clinically significant infestation.
Risk Factors
- Advanced age (prevalence increases dramatically with age)
- Immunocompromised states
- Rosacea
- Poor lid hygiene
- Seborrheic dermatitis
- Treatment-resistant blepharitis or MGD
Clinical Presentation
The pathognomonic sign is cylindrical dandruff (CD) — translucent, sleeve-like deposits at the base of the lashes that cannot be removed with routine lid scrubs. Patients report itching (often the predominant symptom), burning, foreign body sensation, and lid margin discomfort. Lid margin erythema, telangiectasia, and meibomian gland dysfunction are common associated findings. Symptoms are often chronic and treatment-resistant with conventional blepharitis therapy.
Diagnostic Pearls
- Cylindrical dandruff at the lash base is pathognomonic — look for translucent, sleeve-like deposits that differ from the hard scales of staphylococcal blepharitis.
- Itching is the dominant symptom in Demodex blepharitis — more prominent than in staphylococcal or seborrheic forms.
- Epilated lashes examined under microscopy can directly demonstrate mites — useful for patient education and confirmation.
- Consider Demodex in any patient with treatment-resistant blepharitis or MGD.
Differential Diagnosis
- Staphylococcal anterior blepharitis
- Seborrheic blepharitis
- Ocular rosacea
- Allergic contact dermatitis
- Pediculosis (Phthirus pubis — pubic lice)
Evidence-Based Management
Xdemvy® (iotilaner 0.5% ophthalmic solution) is the first FDA-approved treatment for Demodex blepharitis — applied twice daily for 6 weeks, it kills mites by inhibiting GABA-gated chloride channels. Prior to Xdemvy, management relied on tea tree oil (terpinen-4-ol) lid scrubs, which have anti-Demodex activity but require prolonged use and cause ocular surface irritation at higher concentrations. Lid hygiene with hypochlorous acid reduces bacterial co-colonization. Treatment of household contacts and attention to potential sources of re-infestation (shared pillowcases, towels) may reduce recurrence.
Monitoring & Follow-Up
Reassess at 6–8 weeks after completing Xdemvy treatment to evaluate response. Cylindrical dandruff resolution and symptom improvement are the primary endpoints. Recurrence is possible — long-term lid hygiene maintenance reduces re-infestation risk.
Clinical Pearls
- Cylindrical dandruff is the key diagnostic sign — it is pathognomonic and should be actively sought at every blepharitis evaluation.
- Xdemvy's 6-week treatment course is finite — patient education about the defined treatment duration improves compliance.
- Tea tree oil at concentrations > 50% is toxic to the ocular surface — only use formulations specifically designed for periocular use.
- Demodex infestation is not a hygiene failure — it is a near-universal finding in older adults; frame it clinically, not as a personal failing.
Related Therapeutics — Clinician's Companion
- Lid Margin & Demodex — Xdemvy®, Lid Hygiene (Clinician's Companion)
Key References
- 1.Gao YY, et al. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005.
- 2.Yeu E, et al. Saturn-1 Trial: Iotilaner Ophthalmic Solution 0.5% for Demodex Blepharitis. Am J Ophthalmol. 2023.
- 3.Fromstein SR, et al. Demodex blepharitis: clinical perspectives. Clin Ophthalmol. 2018.
This entry is an educational reference designed to support clinical reasoning and awareness. It does not constitute medical advice, establish a standard of care, or replace individualized patient assessment. Clinicians should consult current guidelines and applicable clinical resources when making patient care decisions.